Australia and New Zealand Diabetes Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Market is segmented by Management Devices (Insulin Pumps, Insulin Pens, Syringes, Cartridges, and Jet Injectors) and Monitoring Devices (Self-monitoring Blood Glucose and Continuous Glucose Monitoring), and Geography.

Market Snapshot

Picture1
Study Period: 2018 - 2026
Base Year: 2020
CAGR:

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

  • Australia and New Zealand Diabetes Devices Market, expected to register a CAGR of about 7.7% during the forecast period (2019-2024).
  • A holistic study of the market studied has been carried out by incorporating various factors, extending from country-specific demographic conditions and business cycles to market-specific microeconomic influences, which were needed to analyze future trends.
  • The research uncovers many paradigm shifts in the market studied, in terms of regional competitive advantage and dynamics, primarily to services.

Scope of the Report

Australia and New Zealand Diabetes Devices Market, segmented by management devices (insulin pumps, insulin pens, syringes, cartridges, and jet injectors) and monitoring devices (self-monitoring blood glucose and continuous glucose monitoring), and geography.

By Monitoring Devices Self-Monitoring Blood Glucose Glucometer Devices
Blood Glucose Test Strips
Lancets
Continuous Glucose Monitoring Sensors
Receivers
By Management Devices Insulin Pump Insulin Pump Device
Insulin Pump Reservoir
Infusion Set
Syringes Syringes
Cartridges Cartridges
Disposable Pens Disposable Pens
Jet Injectors Jet Injectors
By Geography Australia
New Zealand
By product
By Monitoring Devices, Value & Volume (2012-2024)
Self-Monitoring Blood Glucose
Glucometer Devices
Blood Glucose Test Strips
Lancets
Continuous Glucose Monitoring
Sensors
Receivers
By Management Devices, Value & Volume (2012-2024)
Insulin Pump
Insulin Pump Device
Insulin Pump Reservoir
Infusion Set
Syringes
Cartridges
Disposable Pens
Jet Injectors
Geography
Australia
By Monitoring Devices (Glucometer Devices, Blood Glucose Test Strips, Lancets, Sensors, Receivers)
By Management Devices (Insulin Pump Device, Insulin Pump Reservior, Infusion Set, Syringes, Cartridges, Disposable pens, Jet Injectors)
New Zealand
By Monitoring Devices (Glucometer Devices, Blood Glucose Test Strips, Lancets, Sensors, Receivers)
By Management Devices (Insulin Pump Device, Insulin Pump Reservior, Infusion Set, Syringes, Cartridges, Disposable pens, Jet Injectors)

Report scope can be customized per your requirements. Click here.

Key Market Trends

Between the two countries, Australia dominated the market with the highest market share.

  • The market studied accounted for USD 0.29 billion in 2018 and is expected to reach USD 0.46 billion by 2024, witnessing a CAGR of 7.7% for 2019-2024.
  • Between Australia and New Zealand, Australia dominated the market with the highest market share 86.2%.
  • Australia having the highest market share because in Australia, Around 1.31 million patients were diagnosed with diabetes in 2018, and more than 100,000 people developed diabetes during the same year.
  • The diabetes population in Australia is expected to reach 1.55 million by 2024. Diabetes has become the biggest challenge in the country.
Picture2

Monitoring devices holds the highest market with USD 0.16 billion.

  • In Australia and New Zealand Diabetes Devices Market, Monitoring devices holds the highest market with USD 0.16 billion. 
  • Innovations in the Monitoring devices market help to increase the market of Australia and New Zealand Diabetes Monitoring devices market, like continuous glucose monitors (CGM), help the patients to measure the blood glucose levels with zero finger pricks.
  • In New Zealand, Pharmac (Pharmaceuticals Management Agency) is funding most health care consumables. And started funding on care sense pro blood glucose test strips from August 2018 until 2022. In New Zealand, about 12,000  patients are using test strips frequently.

 

Picture3

Competitive Landscape

There have been constant innovations driven by manufacturers to compete and struggle in the market. The major players, such as Roche, resort to inorganic market strategies, such as mergers and acquisitions, to establish market dominance, while also adhering to organic growth strategies, which is evident from the R&D spending of these companies. Examples of a few strategic outcomes include:

  • Roche completed the acquisition of Flatiron Health in 2018
  • In 2018, The Ascensia diabetes company’s product- Contour next blood glucose monitoring system complies with the study protocol defined in recently published independent accuracy assessment by the diabetes technology society

 

 

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Drivers

    3. 4.3 Restraints

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Consumers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products and Services

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. Market Segmentation

    1. 5.1 By product

      1. 5.1.1 By Monitoring Devices, Value & Volume (2012-2024)

        1. 5.1.1.1 Self-Monitoring Blood Glucose

          1. 5.1.1.1.1 Glucometer Devices

          2. 5.1.1.1.2 Blood Glucose Test Strips

          3. 5.1.1.1.3 Lancets

        2. 5.1.1.2 Continuous Glucose Monitoring

          1. 5.1.1.2.1 Sensors

          2. 5.1.1.2.2 Receivers

      2. 5.1.2 By Management Devices, Value & Volume (2012-2024)

        1. 5.1.2.1 Insulin Pump

          1. 5.1.2.1.1 Insulin Pump Device

          2. 5.1.2.1.2 Insulin Pump Reservoir

          3. 5.1.2.1.3 Infusion Set

        2. 5.1.2.2 Syringes

        3. 5.1.2.3 Cartridges

        4. 5.1.2.4 Disposable Pens

        5. 5.1.2.5 Jet Injectors

    2. 5.2 Geography

      1. 5.2.1 Australia

        1. 5.2.1.1 By Monitoring Devices (Glucometer Devices, Blood Glucose Test Strips, Lancets, Sensors, Receivers)

        2. 5.2.1.2 By Management Devices (Insulin Pump Device, Insulin Pump Reservior, Infusion Set, Syringes, Cartridges, Disposable pens, Jet Injectors)

      2. 5.2.2 New Zealand

        1. 5.2.2.1 By Monitoring Devices (Glucometer Devices, Blood Glucose Test Strips, Lancets, Sensors, Receivers)

        2. 5.2.2.2 By Management Devices (Insulin Pump Device, Insulin Pump Reservior, Infusion Set, Syringes, Cartridges, Disposable pens, Jet Injectors)

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Abbott

      1. 6.1.1 Overview

      2. 6.1.2 Products and Strategies

      3. 6.1.3 Recent Development

    2. 6.2 Roche

      1. 6.2.1 Overview

      2. 6.2.2 Products and Strategies

      3. 6.2.3 Recent Development

    3. 6.3 Johnson & Johnson

      1. 6.3.1 Overview

      2. 6.3.2 Products and Strategies

      3. 6.3.3 Recent Development

    4. 6.4 Dexcom

      1. 6.4.1 Overview

      2. 6.4.2 Products and Strategies

      3. 6.4.3 Recent Development

    5. 6.5 Becton and Dickenson

      1. 6.5.1 Overview

      2. 6.5.2 Products and Strategies

      3. 6.5.3 Recent Development

    6. 6.6 Medtronic

      1. 6.6.1 Overview

      2. 6.6.2 Products and Strategies

      3. 6.6.3 Recent Development

    7. 6.7 Insulet

      1. 6.7.1 Overview

      2. 6.7.2 Products and Strategies

      3. 6.7.3 Recent Development

    8. 6.8 Ypsomed

      1. 6.8.1 Overview

      2. 6.8.2 Products and Strategies

      3. 6.8.3 Recent Development

    9. 6.9 Novo Nordisk

      1. 6.9.1 Overview

      2. 6.9.2 Products and Strategies

      3. 6.9.3 Recent Development

    10. 6.10 Sanofi

      1. 6.10.1 Overview

      2. 6.10.2 Products and Strategies

      3. 6.10.3 Recent Development

    11. 6.11 Eli Lilly

      1. 6.11.1 Overview

      2. 6.11.2 Products and Strategies

      3. 6.11.3 Recent Development

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Australia and New Zealand Diabetes Devices Market market is studied from 2018 - 2026.

The Australia and New Zealand Diabetes Devices Market is valued at 7.7% in 2018.

Novo Nordisk, Dexcom, Becton Dickinson and Company, Abbott are the major companies operating in Australia and New Zealand Diabetes Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!